Publications by authors named "Nadav Rinott"

Background: Websites serve as a source of medical information for a large part of the public, some claim to be a substitute for a physician's consultation. Many patients meet a physician after conducting internet research. Medical staff are concerned that internet sources of information are unreliable and may lead to erroneous decisions by patients.

View Article and Find Full Text PDF

Over the years total hip arthroplasty had turned from a procedure indicated for elderly, low functioning patients, into a procedure indicated also for younger patients who are interested in a well-functioning hip joint to maintain their active lifestyle. Previously, posterior approach was most commonly utilized, however in recent years, due to the accumulating evidence regarding the advantages of the anterior approach, an increase in the prevalence of the anterior approach is noted. In contrast to other surgical approaches, the anterior approach "respects" inter-muscular and inter-nervous planes and therefore is perceived as associates with less pain, faster rehabilitation, and a good stability relative to other approaches.

View Article and Find Full Text PDF

We are now standing four decades after the 'running revolution' which occurred during the 70's of the previous century. Despite the developments that have occurred in medicine and the large budgets invested in the development of the sport's equipment, the runner's morbidity has not changed. In this article, we would like to review the changes in running that occurred throughout the years, as well as the common risk factors for running injuries.

View Article and Find Full Text PDF

Acquired idiopathic thrombotic thrombocytopenic purpura (I-TTP) is a life-threatening microangiopathic disorder usually treated with therapeutic plasma exchange (TPE). The current study assessed the role of rituximab in the treatment of complicated I-TTP. The sequence of TTP events was compared in a group of I-TTP patients treated with TPE and a cohort of refractory or relapsed patients who also received rituximab.

View Article and Find Full Text PDF